British households still 'saddled with highest energy bills'
"However, even with this reduction, the price cap is still almost 50% higher than when it was first introduced in 20191."
'For over half a decade, British households have been saddled with some of the highest energy bills of any developed country in the world.
"The average UK household currently pays around 27% more for its energy than their European neighbours.
"So, while this latest move from Ofgem is a step in the right direction, many households will still be feeling the impact of high energy bills.'
Recommended reading:
Ashton continued 'In recent months we've worked with our energy partners to bring more competition into the market with below-price cap deals, helping households save up to £4333 on their energy bills, and with 92% of customers on a standard variable rate4, switching can make a real difference to your bills.'
From 10am today (Friday 23rd May), MoneySuperMarket customers will have access to a new exclusive fixed energy deal from E.ON Next, below the new energy price cap5.
Priced at £1,573 for a 12-month fix, the E.ON Next 12m fixed v56 tariff is £147 below the current energy price cap, and is available to both new and existing E.ON customers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
14 minutes ago
- Reuters
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
July 28 (Reuters) - The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said. Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S. On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs. The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%. Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered. UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland. ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear "until a trade deal is inked." Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer. Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers. Earlier this month, Sanofi ( opens new tab said it will sell a manufacturing facility in New Jersey to Thermo Fisher (TMO.N), opens new tab, where the French drugmaker's therapies will continue to be manufactured. Roche's (ROG.S), opens new tab CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs. UBS' Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz (SDZ.S), opens new tab for this year should mostly be manageable. Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday.
Reuters
14 minutes ago
- Reuters
UK's Wise shareholders approve move to a US stock exchange
July 28 (Reuters) - Shareholders of British fintech Wise Plc (WISEa.L), opens new tab on Monday approved plans at an extraordinary general meeting to shift the company's primary stock market listing to the United States.
Western Telegraph
39 minutes ago
- Western Telegraph
Farm plastics plan by NRW to cut River Cleddau pollution
Natural Resources Wales (NRW) has set up drop-off centres within the rivers Cleddau, Teifi, Tywi and Usk catchment areas where farmers can drop off silage bale wrap, clamp cover sheeting, fertiliser and feed bags, and feed buckets. The scheme is supported by Agriculture Plastics Environment, Birch Farm Plastics and Afonydd Cymru, who will provide the service at a reduced rate compared to charges for on-farm collection. NRW wants to recycle an additional 200t of farm plastics through the trial scheme. Chris Thomas, senior land management officer at Four Rivers for Life, says farm plastics have been found in the Cleddau, Teifi and Tywi rivers. 'Rivers can only fully perform this function and support farmers if they are healthy and free from pollution and plastic waste,'' he said. Don't miss our next edition of Pembrokeshire Farmer, available free inside the Western Telegraph on July 30 A report in 2023 by non-governmental organisation Wrap found that the UK has an agri-plastic recycling rate of 20-30%, which is significantly lower than other European countries, including Germany, France and Ireland who have recycling rates of 65%, 80% and 90% respectively. These countries operate drop off centres and these significantly help farmers recycle their used farm plastics. In 2024, West Wales Rivers Trust (WWRT) carried out a survey of 100 farms to review current practices on the disposal of agricultural plastics in Carmarthenshire and across Wales. The results showed that cost was one of the main barriers preventing more farmers recycling their silage plastic waste. Cheryl Birch, director at Birch Farm Plastics, which is partnering NRW in the scheme, said the company's costs can be lower when collecting from drop-off centres and those savings can therefore be passed onto farmers. One of the dedicated drop-off sites is at Crymych. More information can be found at
